← Back to headlines
Wave Life Sciences Stock Plunges After Disappointing Obesity Drug Data
Wave Life Sciences experienced a significant drop in its stock market value today, March 26, following the release of disappointing data from its high-dose obesity drug trials.
26 Mar, 21:50 — 26 Mar, 21:50
Sources
Showing 1 of 1 sources
Related Stories
World Bank Provides $200 Million Emergency Aid to Colombia After Earthquake
3h ago
Oil and Treasury Yields Rise as US Threatens Iran with More Sanctions
7h ago
Danish Apple Retailer Humac Enters Reconstruction, Temporarily Closes Stores
7h ago
Hong Kong Raises Economic Growth Forecast After Strong Performance
9h ago